Antitumor agent-61
Antitumor agent-61 (Compound 9b), Irinotecan (Ir) derivative, is a potential antitumor agent. Antitumor agent-61 displays potent activity with IC50s of 0.92, 1.39, 1.75, 2.20, 3.05 and 3.23 μM against five human cancer cells SK-OV-3, SK-OV-3/CDDP, U2OS, MCF-7, A549 and MG-63, respectively. Antitumor agent-61 induces SK-OV-3 cells apoptosis through mitochondrion pathways.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- CAS No.: 2408917-12-2
- 화학식: C54H63FN5O10P
- 분자량:992.08
-
보관:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| A549 | IC50 |
3.05 μM
Compound: 9b
|
Cytotoxicity against human A549 cells assessed as reduction in cell growth by MTT assay
Cytotoxicity against human A549 cells assessed as reduction in cell growth by MTT assay
|
[PMID: 31972391] |
| MCF7 | IC50 |
2.2 μM
Compound: 9b
|
Cytotoxicity against human MCF-7 cells assessed as reduction in cell growth by MTT assay
Cytotoxicity against human MCF-7 cells assessed as reduction in cell growth by MTT assay
|
[PMID: 31972391] |
| MG-63 | IC50 |
3.23 μM
Compound: 9b
|
Cytotoxicity against human MG-63 cells assessed as reduction in cell growth by MTT assay
Cytotoxicity against human MG-63 cells assessed as reduction in cell growth by MTT assay
|
[PMID: 31972391] |
| SK-OV-3 | IC50 |
0.92 μM
Compound: 9b
|
Cytotoxicity against human SK-OV-3 cells assessed as reduction in cell growth by MTT assay
Cytotoxicity against human SK-OV-3 cells assessed as reduction in cell growth by MTT assay
|
[PMID: 31972391] |
| U2OS | IC50 |
1.75 μM
Compound: 9b
|
Cytotoxicity against human U2OS cells assessed as reduction in cell growth by MTT assay
Cytotoxicity against human U2OS cells assessed as reduction in cell growth by MTT assay
|
[PMID: 31972391] |
Antitumor agent-61 (compound 6b) shows anti-proliferation activity with IC50 values of 3.05, 2.20, 3.23, 1.75, 0.92 and 1.39 μM for A549, MCF-7, MG-63, U2OS, SK-OV-3 and SK-OV-3/CDDP cells[1].
Antitumor agent-61 (compound 6b) (50-150 μM) shows a certain inhibitory activity against Topo I at 150 μM[1].
Antitumor agent-61 (compound 6b) (5-10 μM; 24 hours, SK-OV-3 cells) induces apoptosis through mitochondrial pathway. Decrease the MMP level and increase ROS level in a dose-dependent manner [1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:SK-OV-3 cells
-
Concentration:5.0 and 10 μM
-
Incubation Time:24 hours
-
Result:Increased the percentage of apoptosis cells (including the early and late apoptosis) from 21.11% (5 μM) to 32.27% (10 μM), respectively and the apoptosis rate was significantly greater than that of Ir.
-
Cell Line:SK-OV-3 cells
-
Concentration:5.0 and 10 μM
-
Incubation Time:24 hours
-
Result:Increased the percentage of S stage in a dose-dependent manner.
-
Cell Line:SK-OV-3 cells
-
Concentration:5.0 and 10 μM
-
Incubation Time:24 hours
-
Result:Decreased the expression of antiapoptotic protein Bcl-2, while increased pro-apoptotic Bax and caspase expression.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c nude mice with SK-OV-3 xenograft[1]
-
Dosage:10 and 20 mg/kg
-
Administration:Subcutaneous injection; Twice daily, for 28 days.
-
Result:Suppressed tumor growth by 47.7% and 56.8% for 10 and 20 mg/kg, respectively, without affecting body weight or causing any overt adverse effects.
Chemical Information
-
CAS No. 2408917-12-2
-
분자량 992.08
-
화학식 C54H63FN5O10P
-
SMILES
O=C(N1CCC(CC1)N2CCCCC2)OC3=CC4=C(CC)C5=C(C6=CC7=C(COC(C7(CC)OC(CCCC8=CC=C(NC(P(OCC)(OCC)=O)C9=CC=C(C=C9)F)C=C8)=O)=O)C(N6C5)=O)N=C4C=C3
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Please store the product under the recommended conditions in the Certificate of Analysis.
순도&문서
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)